Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
US ˙ NasdaqCM ˙ US00653A1079

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Krishna Kittu Kolluri. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Krishna Kittu Kolluri har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:HLGN / Heliogen, Inc. 10% Owner 728.950
US:AKAO / Achaogen, Inc. 10% Owner 5.215.128
US:TCON / TRACON Pharmaceuticals, Inc. 10% Owner 2.758.039
US:RARX / Ra Pharmaceuticals, Inc. 10% Owner 0
US:ROKA / Roka Bioscience, Inc. 10% Owner 4.000
US:ZSAN / Zosano Pharma Corp 10% Owner 2.052.805
10% Owner 3.554.610
US:ILIU / Interleukin Genetics, Inc. 10% Owner 20.120.724
US:ARDX / Ardelyx, Inc. 10% Owner 2.665.519
US:OPWR / Opower, Inc. 10% Owner 0
US:AVEO / AVEO Pharmaceuticals Inc 10% Owner 20.725.388
US:TSRO / TESARO, Inc. 10% Owner 711.179
US:TRIV / TriVascular Technologies, Inc. 10% Owner 0
US:EPZM / Epizyme Inc 10% Owner 5.854.351
US:ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock) 10% Owner 118.538.000
US:SUPN / Supernus Pharmaceuticals, Inc. 10% Owner 20.547
US:AVTX / Avalo Therapeutics, Inc. 10% Owner 0
US:MIRN / Mirna Therapeutics, Inc. 10% Owner 2.971.517
US:ABIO / ARCA biopharma, Inc. 10% Owner 20.442.930
Director, 10% Owner 41.580
US:HPTX / Hyperion Therapeutics Inc 10% Owner 0
US:CSBR / Champions Oncology, Inc. 10% Owner 37.500.000
US:BOX / Box, Inc. 10% Owner 2.091.457
US:TRVN / Trevena, Inc. 10% Owner 4.811.691
US:DATA / Tableau Software, Inc. 10% Owner 1.964.192
US:CVT / Cvent Holding Corp 10% Owner 65
US:DERM / Journey Medical Corporation 10% Owner 0
10% Owner 4.659.333
US:LOXO / Loxo Oncology, Inc. 10% Owner 0
US:CRCM / Care.com, Inc. 10% Owner 0
US:ECOM / ChannelAdvisor Corp 10% Owner 0
US:GLYC / GlycoMimetics, Inc. 10% Owner 0
US:ADNC / Audience Inc 10% Owner 0
10% Owner 1.205
US:GRPN / Groupon, Inc. 10% Owner 4.016
Director, 10% Owner 0
US:CLVS / Clovis Oncology Inc 10% Owner 77
US:WDAY / Workday, Inc. 10% Owner 4.642.425
US:MM / 10% Owner 8.196.614
US:FIO / Franklin Income Opportunities Fund 10% Owner 0
10% Owner 675
US:FOLD / Amicus Therapeutics, Inc. 10% Owner 4.584.311
US:ECHO / Echo Global Logistics Inc 10% Owner 97
US:JNPR / Juniper Networks, Inc. GM, Security Products Group 288.014
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Krishna Kittu Kolluri. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock) – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock) Insider Trades
Insidersalg ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock) – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock) Insider Trades
Insiderkøb ARDX / Ardelyx, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2014-06-24 ARDX New Enterprise Associates 12, Limited Partnership 510.442 14,0000 510.442 14,0000 7.146.188 162 32.89 9.642.249 134,93

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

ARDX / Ardelyx, Inc. Insider Trades
Insidersalg ARDX / Ardelyx, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2014-12-29 ARDX KOLLURI KRISHNA KITTU 223 20,0891 223 20,0891 4.480 128 8.32 -2.624 -58,58
2014-12-29 ARDX KOLLURI KRISHNA KITTU 22 20,0891 22 20,0891 442
2014-12-29 ARDX KOLLURI KRISHNA KITTU 22 20,0891 22 20,0891 442

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

ARDX / Ardelyx, Inc. Insider Trades
Insiderkøb AVTX / Avalo Therapeutics, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

AVTX / Avalo Therapeutics, Inc. Insider Trades
Insidersalg AVTX / Avalo Therapeutics, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

AVTX / Avalo Therapeutics, Inc. Insider Trades
Insiderkøb BOX / Box, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

BOX / Box, Inc. Insider Trades
Insidersalg BOX / Box, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

BOX / Box, Inc. Insider Trades
Insiderkøb CSBR / Champions Oncology, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

CSBR / Champions Oncology, Inc. Insider Trades
Insidersalg CSBR / Champions Oncology, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

CSBR / Champions Oncology, Inc. Insider Trades
Insiderkøb DERM / Journey Medical Corporation – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

DERM / Journey Medical Corporation Insider Trades
Insidersalg DERM / Journey Medical Corporation – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

DERM / Journey Medical Corporation Insider Trades
Insiderkøb FOLD / Amicus Therapeutics, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2012-03-07 FOLD NEW ENTERPRISE ASSOCIATES 11 LP 925.154 5,7000 925.154 5,7000 5.273.378 133 6.51 749.376 14,21

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

FOLD / Amicus Therapeutics, Inc. Insider Trades
Insidersalg FOLD / Amicus Therapeutics, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

FOLD / Amicus Therapeutics, Inc. Insider Trades
Insiderkøb GRPN / Groupon, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

GRPN / Groupon, Inc. Insider Trades
Insidersalg GRPN / Groupon, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2013-09-11 GRPN KOLLURI KRISHNA KITTU 260 11,4000 13 228,0000 2.964 238 5.3300 -2.895 -97,66
2013-09-11 GRPN KOLLURI KRISHNA KITTU 260 11,4050 13 228,1000 2.965

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

GRPN / Groupon, Inc. Insider Trades
Insiderkøb SUPN / Supernus Pharmaceuticals, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2012-05-04 SUPN NEW ENTERPRISE ASSOCIATES 11 LP 4.400.000 5,0000 4.400.000 5,0000 22.000.000 76 14.86 43.384.000 197,20

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

SUPN / Supernus Pharmaceuticals, Inc. Insider Trades
Insidersalg SUPN / Supernus Pharmaceuticals, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

SUPN / Supernus Pharmaceuticals, Inc. Insider Trades
Insiderkøb SYBX / Synlogic, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

SYBX / Synlogic, Inc. Insider Trades
Insidersalg SYBX / Synlogic, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

SYBX / Synlogic, Inc. Insider Trades
Insiderkøb TRVN / Trevena, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2014-12-10 TRVN New Enterprise Associates 12, Limited Partnership 1.000.000 4,0000 40.000 100,0000 4.000.000 282 332.5 9.300.000 232,50
2014-02-05 TRVN New Enterprise Associates 12, Limited Partnership 472.410 7,0000 18.896 175,0000 3.306.870

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

TRVN / Trevena, Inc. Insider Trades
Insidersalg TRVN / Trevena, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

TRVN / Trevena, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Krishna Kittu Kolluri som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2022-08-26 2022-08-25 4 HLGN Heliogen, Inc.
Common Stock
S - Sale -4.305 728.950 -0,59 2,48 -10.694 1.810.858
2022-08-26 2022-08-25 4 HLGN Heliogen, Inc.
Common Stock
S - Sale -106.958 18.086.126 -0,59 2,48 -265.705 44.929.554
2022-08-26 2022-08-24 4 HLGN Heliogen, Inc.
Common Stock
S - Sale -5.366 733.255 -0,73 2,55 -13.697 1.871.707
2022-08-26 2022-08-24 4 HLGN Heliogen, Inc.
Common Stock
S - Sale -133.299 18.193.084 -0,73 2,55 -340.259 46.439.666
2022-08-24 2022-08-23 4 HLGN Heliogen, Inc.
Common Stock
S - Sale -6.182 738.621 -0,83 2,42 -14.951 1.786.281
2022-08-24 2022-08-23 4 HLGN Heliogen, Inc.
Common Stock
S - Sale -153.565 18.326.383 -0,83 2,42 -371.382 44.320.525
2022-08-24 2022-08-22 4 HLGN Heliogen, Inc.
Common Stock
S - Sale -8.593 744.803 -1,14 2,54 -21.788 1.888.448
2022-08-24 2022-08-22 4 HLGN Heliogen, Inc.
Common Stock
S - Sale -213.462 18.479.948 -1,14 2,54 -541.233 46.855.908
2022-08-22 2022-08-19 4 HLGN Heliogen, Inc.
Common Stock
S - Sale -4.026 753.396 -0,53 2,43 -9.769 1.828.115
2022-08-22 2022-08-19 4 HLGN Heliogen, Inc.
Common Stock
S - Sale -100.022 18.693.410 -0,53 2,43 -242.703 45.359.559
2022-08-22 2022-08-18 4 HLGN Heliogen, Inc.
Common Stock
S - Sale -5.455 757.422 -0,72 2,49 -13.557 1.882.345
2022-08-22 2022-08-18 4 HLGN Heliogen, Inc.
Common Stock
S - Sale -135.501 18.793.432 -0,72 2,49 -336.747 46.705.437
2022-08-18 2022-08-17 4 HLGN Heliogen, Inc.
Common Stock
S - Sale -7.820 762.877 -1,01 2,53 -19.770 1.928.629
2022-08-18 2022-08-17 4 HLGN Heliogen, Inc.
Common Stock
S - Sale -194.263 18.928.933 -1,02 2,53 -491.116 47.854.236
2022-08-18 2022-08-16 4 HLGN Heliogen, Inc.
Common Stock
S - Sale -6.787 770.697 -0,87 2,48 -16.847 1.913.024
2022-08-18 2022-08-16 4 HLGN Heliogen, Inc.
Common Stock
S - Sale -168.611 19.123.196 -0,87 2,48 -418.526 47.467.597
2022-08-16 2022-08-15 4 HLGN Heliogen, Inc.
Common Stock
S - Sale -13.978 777.484 -1,77 2,45 -34.246 1.904.836
2022-08-16 2022-08-15 4 HLGN Heliogen, Inc.
Common Stock
S - Sale -347.211 19.291.807 -1,77 2,45 -850.667 47.264.927
2022-08-16 2022-08-12 4 HLGN Heliogen, Inc.
Common Stock
S - Sale -12.748 791.462 -1,59 2,84 -36.174 2.245.853
2022-08-16 2022-08-12 4 HLGN Heliogen, Inc.
Common Stock
S - Sale -316.658 19.639.018 -1,59 2,84 -898.549 55.727.677
2022-08-12 2022-08-11 4 HLGN Heliogen, Inc.
Common Stock
S - Sale -6.258 804.210 -0,77 2,66 -16.626 2.136.545
2022-08-12 2022-08-11 4 HLGN Heliogen, Inc.
Common Stock
S - Sale -155.465 19.955.676 -0,77 2,66 -413.024 53.016.244
2022-08-12 2022-08-10 4 HLGN Heliogen, Inc.
Common Stock
S - Sale -15.940 810.468 -1,93 2,85 -45.442 2.310.482
2022-08-12 2022-08-10 4 HLGN Heliogen, Inc.
Common Stock
S - Sale -395.957 20.111.141 -1,93 2,85 -1.128.794 57.332.841
2022-08-10 2022-08-09 4 HLGN Heliogen, Inc.
Common Stock
S - Sale -11.109 826.408 -1,33 2,65 -29.481 2.193.122
2022-08-10 2022-08-09 4 HLGN Heliogen, Inc.
Common Stock
S - Sale -275.941 20.507.098 -1,33 2,65 -732.292 54.421.737
2022-08-10 2022-08-08 4 HLGN Heliogen, Inc.
Common Stock
S - Sale -8.939 837.517 -1,06 2,61 -23.371 2.189.688
2022-08-10 2022-08-08 4 HLGN Heliogen, Inc.
Common Stock
S - Sale -222.053 20.783.039 -1,06 2,61 -580.558 54.337.255
2022-08-08 2022-08-05 4 HLGN Heliogen, Inc.
Common Stock
S - Sale -7.475 846.456 -0,88 2,52 -18.833 2.132.646
2022-08-08 2022-08-05 4 HLGN Heliogen, Inc.
Common Stock
S - Sale -185.696 21.005.092 -0,88 2,52 -467.861 52.922.329
2022-08-08 2022-08-04 4 HLGN Heliogen, Inc.
Common Stock
S - Sale -2.958 853.931 -0,35 2,58 -7.630 2.202.715
2022-08-08 2022-08-04 4 HLGN Heliogen, Inc.
Common Stock
S - Sale -72.156 21.190.788 -0,34 2,58 -186.126 54.661.638
2022-08-03 2022-08-03 4 HLGN Heliogen, Inc.
Common Stock
S - Sale -6.128 856.889 -0,71 2,62 -16.074 2.247.706
2022-08-03 2022-08-03 4 HLGN Heliogen, Inc.
Common Stock
S - Sale -153.566 21.262.944 -0,72 2,62 -402.819 55.774.828
2022-08-03 2022-08-02 4 HLGN Heliogen, Inc.
Common Stock
S - Sale -13.629 863.017 -1,55 2,62 -35.666 2.258.429
2022-08-03 2022-08-02 4 HLGN Heliogen, Inc.
Common Stock
S - Sale -338.547 21.416.510 -1,56 2,62 -885.944 56.044.865
2022-08-03 2022-08-01 4 HLGN Heliogen, Inc.
Common Stock
S - Sale -2.238 876.646 -0,25 2,35 -5.264 2.061.959
2022-08-03 2022-08-01 4 HLGN Heliogen, Inc.
Common Stock
S - Sale -55.601 21.755.057 -0,25 2,35 -130.779 51.170.070
2022-07-29 2022-07-29 4 HLGN Heliogen, Inc.
Common Stock
S - Sale -11.161 878.884 -1,25 2,46 -27.436 2.160.473
2022-07-29 2022-07-29 4 HLGN Heliogen, Inc.
Common Stock
S - Sale -277.242 21.810.658 -1,26 2,46 -681.516 53.614.959
2022-07-29 2022-07-28 4 HLGN Heliogen, Inc.
Common Stock
S - Sale -7.333 890.045 -0,82 2,36 -17.324 2.102.731
2022-07-29 2022-07-28 4 HLGN Heliogen, Inc.
Common Stock
S - Sale -182.158 22.087.900 -0,82 2,36 -430.348 52.182.664
2022-07-29 2022-07-27 4 HLGN Heliogen, Inc.
Common Stock
S - Sale -2.830 897.378 -0,31 2,07 -5.861 1.858.649
2022-07-29 2022-07-27 4 HLGN Heliogen, Inc.
Common Stock
S - Sale -70.300 22.270.058 -0,31 2,07 -145.605 46.125.744
2022-07-25 2022-07-21 4 HLGN Heliogen, Inc.
Common Stock
S - Sale -493 900.208 -0,05 2,03 -1.000 1.826.882
2022-07-25 2022-07-21 4 HLGN Heliogen, Inc.
Common Stock
S - Sale -12.267 22.340.358 -0,05 2,03 -24.895 45.337.523
2022-07-20 2022-07-20 4 HLGN Heliogen, Inc.
Common Stock
S - Sale -3.145 900.701 -0,35 2,07 -6.503 1.862.379
2022-07-20 2022-07-20 4 HLGN Heliogen, Inc.
Common Stock
S - Sale -78.128 22.352.625 -0,35 2,07 -161.545 46.218.523
2022-07-20 2022-07-19 4 HLGN Heliogen, Inc.
Common Stock
S - Sale -140 903.846 -0,02 2,01 -281 1.814.923
2022-07-20 2022-07-19 4 HLGN Heliogen, Inc.
Common Stock
S - Sale -3.496 22.430.753 -0,02 2,01 -7.020 45.040.952
2022-07-20 2022-07-18 4 HLGN Heliogen, Inc.
Common Stock
S - Sale -927 903.986 -0,10 2,01 -1.860 1.813.486
2022-07-20 2022-07-18 4 HLGN Heliogen, Inc.
Common Stock
S - Sale -23.030 22.434.249 -0,10 2,01 -46.200 45.005.347
2022-07-14 2022-07-13 4 HLGN Heliogen, Inc.
Common Stock
S - Sale -524 904.913 -0,06 2,02 -1.059 1.829.101
2022-07-14 2022-07-13 4 HLGN Heliogen, Inc.
Common Stock
S - Sale -13.021 22.457.279 -0,06 2,02 -26.319 45.392.898
2022-07-14 2022-07-12 4 HLGN Heliogen, Inc.
Common Stock
S - Sale -2.736 905.437 -0,30 2,07 -5.662 1.873.711
2022-07-14 2022-07-12 4 HLGN Heliogen, Inc.
Common Stock
S - Sale -67.980 22.470.300 -0,30 2,07 -140.678 46.500.039
2022-07-14 2022-07-11 4 HLGN Heliogen, Inc.
Common Stock
S - Sale -3.023 908.173 -0,33 2,13 -6.443 1.935.498
2022-07-14 2022-07-11 4 HLGN Heliogen, Inc.
Common Stock
S - Sale -75.141 22.538.280 -0,33 2,13 -160.140 48.033.582
2022-07-08 2022-07-08 4 HLGN Heliogen, Inc.
Common Stock
S - Sale -5.652 911.196 -0,62 2,27 -12.813 2.065.681
2022-07-08 2022-07-08 4 HLGN Heliogen, Inc.
Common Stock
S - Sale -140.394 22.613.421 -0,62 2,27 -318.273 51.264.625
2022-07-08 2022-07-07 4 HLGN Heliogen, Inc.
Common Stock
S - Sale -3.755 916.848 -0,41 2,21 -8.305 2.027.701
2022-07-08 2022-07-07 4 HLGN Heliogen, Inc.
Common Stock
S - Sale -93.277 22.753.815 -0,41 2,21 -206.291 50.322.337
2022-07-08 2022-07-06 4 HLGN Heliogen, Inc.
Common Stock
S - Sale -4.847 920.603 -0,52 2,09 -10.122 1.922.587
2022-07-08 2022-07-06 4 HLGN Heliogen, Inc.
Common Stock
S - Sale -120.404 22.847.092 -0,52 2,09 -251.452 47.713.867
2022-07-01 2022-07-01 4 HLGN Heliogen, Inc.
Common Stock
S - Sale -4.899 925.450 -0,53 2,02 -9.892 1.868.576
2022-07-01 2022-07-01 4 HLGN Heliogen, Inc.
Common Stock
S - Sale -121.701 22.967.496 -0,53 2,02 -245.726 46.373.671
2022-07-01 2022-06-30 4 HLGN Heliogen, Inc.
Common Stock
S - Sale -5.748 930.349 -0,61 2,12 -12.187 1.972.619
2022-07-01 2022-06-30 4 HLGN Heliogen, Inc.
Common Stock
S - Sale -142.792 23.089.197 -0,61 2,12 -302.762 48.956.024
2022-07-01 2022-06-29 4 HLGN Heliogen, Inc.
Common Stock
S - Sale -9.645 936.097 -1,02 2,07 -20.010 1.942.027
2022-07-01 2022-06-29 4 HLGN Heliogen, Inc.
Common Stock
S - Sale -239.599 23.231.989 -1,02 2,07 -497.072 48.197.084
2022-07-01 3 HLGN Heliogen, Inc.
Common Stock
23.471.588
2022-07-01 3 HLGN Heliogen, Inc.
Common Stock
945.742
2016-12-19 2016-12-19 4 AKAO Achaogen Inc
Common Stock
P - Purchase 500.000 5.215.128 10,60 13,50 6.750.000 70.404.228
2016-11-29 2016-11-29 4 TCON Tracon Pharmaceuticals, Inc.
Common Stock
P - Purchase 869.565 2.758.039 46,05 5,75 4.999.999 15.858.724
2016-10-31 2016-10-31 4 RARX Ra Pharmaceuticals, Inc.
Series B-2 Preferred Stock
C - Conversion -4.362.472 0 -100,00
2016-10-31 2016-10-31 4 RARX Ra Pharmaceuticals, Inc.
Series B-1 Preferred Stock
C - Conversion -4.689.657 0 -100,00
2016-10-31 2016-10-31 4 RARX Ra Pharmaceuticals, Inc.
Series A Preferred Stock
C - Conversion -12.447.605 0 -100,00
2016-10-31 2016-10-31 4 RARX Ra Pharmaceuticals, Inc.
Warrants to Purchase Common Stock
X - Other -80.658 0 -100,00
2016-10-31 2016-10-31 4 RARX Ra Pharmaceuticals, Inc.
Common Stock
P - Purchase 338.462 3.490.073 10,74 13,00 4.400.006 45.370.949
2016-10-31 2016-10-31 4 RARX Ra Pharmaceuticals, Inc.
Common Stock
C - Conversion 623.210 3.151.611 24,65
2016-10-31 2016-10-31 4 RARX Ra Pharmaceuticals, Inc.
Common Stock
C - Conversion 669.951 2.528.401 36,05
2016-10-31 2016-10-31 4 RARX Ra Pharmaceuticals, Inc.
Common Stock
C - Conversion 1.778.227 1.858.450 2.216,60
2016-10-31 2016-10-31 4 RARX Ra Pharmaceuticals, Inc.
Common Stock
S - Sale -435 80.223 -0,54 13,00 -5.655 1.042.899
2016-10-31 2016-10-31 4 RARX Ra Pharmaceuticals, Inc.
Common Stock
X - Other 80.658 80.658 0,07 5.646 5.646
2016-09-30 2016-09-21 4/A ROKA Roka BioScience, Inc.
Series A Convertible Preferred Stock
P - Purchase 4.000 4.000
2016-09-23 2016-09-21 4 ROKA Roka BioScience, Inc.
Warrant to Purchase Common Stock (right to buy)
P - Purchase 5.714.286 5.714.286
2016-09-23 2016-09-21 4 ROKA Roka BioScience, Inc.
Series A Convertible Preferred Stock
P - Purchase 4.000 4.000
2016-09-20 2016-09-16 4 ZSAN Zosano Pharma Corp
Common Stock
S - Sale -7.471 2.052.805 -0,36 0,75 -5.603 1.539.604
2016-09-15 2016-09-13 4 ZSAN Zosano Pharma Corp
Common Stock
S - Sale -10.000 2.060.276 -0,48 0,74 -7.400 1.524.604
2016-09-15 2016-09-14 4 PTI PROTEOSTASIS THERAPEUTICS, INC.
Common Stock
P - Purchase 461.538 3.554.610 14,92 13,00 5.999.994 46.209.930
2016-08-31 2016-08-29 4 ZSAN Zosano Pharma Corp
Common Stock
S - Sale -50.000 2.070.276 -2,36 1,01 -50.440 2.088.494
2016-08-26 2016-08-24 4 ZSAN Zosano Pharma Corp
Common Stock
S - Sale -1.200 2.120.276 -0,06 1,21 -1.452 2.565.534
2016-08-02 2016-07-29 4 ILIU INTERLEUKIN GENETICS INC
Common Stock Warrant (right to buy)
P - Purchase 20.120.724 20.120.724
2016-08-02 2016-07-29 4 ILIU INTERLEUKIN GENETICS INC
Common Stock
P - Purchase 20.120.724 55.418.811 57,00 0,10 2.000.000 5.508.630
2016-07-21 2016-07-21 4 ZSAN Zosano Pharma Corp
Common Stock
S - Sale -8.989 2.121.476 -0,42 1,33 -11.957 2.821.987
2016-07-21 2016-07-20 4 ZSAN Zosano Pharma Corp
Common Stock
S - Sale -14.158 2.130.465 -0,66 1,24 -17.550 2.640.924
2016-07-21 2016-07-19 4 ZSAN Zosano Pharma Corp
Common Stock
S - Sale -534 2.144.623 -0,02 1,17 -625 2.509.209
2016-07-20 2016-07-18 4 ARDX ARDELYX, INC.
Common Stock
P - Purchase 763.650 2.665.519 40,15 8,73 6.666.664 23.269.981
2016-07-20 2016-07-18 4 ARDX ARDELYX, INC.
Common Stock
P - Purchase 763.650 2.665.519 40,15 8,73 6.666.664 23.269.981
2016-07-20 2016-07-18 4 ARDX ARDELYX, INC.
Common Stock
P - Purchase 763.651 2.665.520 40,15 8,73 6.666.673 23.269.990
2016-07-15 2016-07-13 4 ZSAN Zosano Pharma Corp
Common Stock
S - Sale -13.382 2.145.157 -0,62 1,20 -16.060 2.574.403
2016-06-14 2016-06-14 4 OPWR OPOWER, INC.
Common Stock
U - Other -8.989.766 0 -100,00 10,30 -92.594.590
2016-06-07 3 AKAO Achaogen Inc
Common Stock
9.430.256
2016-06-07 3 AKAO Achaogen Inc
Common Stock
9.430.256
2016-05-17 3 AVEO AVEO PHARMACEUTICALS INC
Common Stock
20.725.388
2016-05-17 3 AVEO AVEO PHARMACEUTICALS INC
Common Stock
20.725.388
2016-03-18 2016-03-18 4 TSRO TESARO, Inc.
Common Stock
P - Purchase 710.429 711.179 94.723,87
2016-03-18 2016-03-18 4 TSRO TESARO, Inc.
Common Stock
P - Purchase 710.429 710.429
2016-02-17 2016-02-17 4 PTI PROTEOSTASIS THERAPEUTICS, INC.
Series B Convertible Redeemable Preferred Stock
C - Conversion -4.423.723 0 -100,00
2016-02-17 2016-02-17 4 PTI PROTEOSTASIS THERAPEUTICS, INC.
Series A Convertible Redeemable Preferred Stock
C - Conversion -13.848.000 0 -100,00
2016-02-17 2016-02-17 4 PTI PROTEOSTASIS THERAPEUTICS, INC.
Common Stock
P - Purchase 900.324 3.093.072 41,06 8,00 7.202.592 24.744.576
2016-02-17 2016-02-17 4 PTI PROTEOSTASIS THERAPEUTICS, INC.
Common Stock
C - Conversion 2.192.748 2.192.748
2016-02-04 2016-02-03 4 TRIV TriVascular Technologies, Inc.
Common Stock
D - Sale to Issuer -3.943.269 0 -100,00
2016-01-14 2016-01-13 4 ARDX ARDELYX, INC.
Common Stock
P - Purchase 500.000 1.901.869 35,67 10,00 5.000.000 19.018.690
2016-01-14 2016-01-13 4 ARDX ARDELYX, INC.
Common Stock
P - Purchase 500.000 1.901.869 35,67 10,00 5.000.000 19.018.690
2016-01-14 2016-01-13 4 ARDX ARDELYX, INC.
Common Stock
P - Purchase 500.000 1.901.869 35,67 10,00 5.000.000 19.018.690
2016-01-12 2016-01-12 4 EPZM Epizyme, Inc.
Common Stock
P - Purchase 1.111.111 5.854.351 23,43 9,00 9.999.999 52.689.159
2016-01-04 3 ADAP Adaptimmune Therapeutics PLC
Ordinary Shares with a nominal value of 0.001 GBP per share
118.538.000
2016-01-04 3 ADAP Adaptimmune Therapeutics PLC
Ordinary Shares with a nominal value of 0.001 GBP per share
118.538.000
2015-11-12 2015-11-11 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
J - Other 10.305 20.547 100,62
2015-11-12 2015-11-11 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
J - Other 1.203 10.242 13,31
2015-11-12 2015-11-11 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
J - Other -1.172.932 0 -100,00
2015-11-12 2015-11-11 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
J - Other 1.172.932 1.172.932
2015-11-12 2015-11-11 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
J - Other -3.820.625 3.820.625 -50,00
2015-10-20 2015-10-20 4 CERC Cerecor Inc.
Series B Convertible Preferred Stock
C - Conversion -16.638.880 0 -100,00
2015-10-20 2015-10-20 4 CERC Cerecor Inc.
Common Stock
C - Conversion 594.245 594.245
2015-10-06 2015-10-06 4 MIRN Mirna Therapeutics, Inc.
Common Stock
P - Purchase 857.142 2.971.517 40,54 7,00 5.999.994 20.800.619
2015-10-06 2015-10-06 4 MIRN Mirna Therapeutics, Inc.
Common Stock
J - Other 31.650 2.114.375 1,52
2015-10-06 2015-10-06 4 MIRN Mirna Therapeutics, Inc.
Common Stock
J - Other 257.516 1.499.166 20,74
2015-10-06 2015-10-05 4 MIRN Mirna Therapeutics, Inc.
Series D Preferred Stock
C - Conversion -583.559 0 -100,00
2015-10-06 2015-10-05 4 MIRN Mirna Therapeutics, Inc.
Series C Preferred Stock
C - Conversion -1.241.650 0 -100,00
2015-10-06 2015-10-05 4 MIRN Mirna Therapeutics, Inc.
Common Stock
C - Conversion 583.559 2.082.725 38,93
2015-10-06 2015-10-05 4 MIRN Mirna Therapeutics, Inc.
Common Stock
C - Conversion 1.241.650 1.241.650
2015-06-17 2015-06-15 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
J - Other 8.094 9.039 856,51
2015-06-17 2015-06-15 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
J - Other 945 945
2015-06-17 2015-06-15 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
J - Other -921.000 0 -100,00
2015-06-17 2015-06-15 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
J - Other 921.000 921.000
2015-06-17 2015-06-15 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
J - Other -3.000.000 7.641.250 -28,19
2015-06-17 3 ABIO ARCA biopharma, Inc.
Common Stock
20.442.930
2015-06-17 3 ABIO ARCA biopharma, Inc.
Common Stock
20.442.930
2015-06-09 2015-06-05 4 ARDX ARDELYX, INC.
Common Stock Warrant (right to buy)
P - Purchase 420.561 420.561 0,12 52.570 52.570
2015-06-09 2015-06-05 4 ARDX ARDELYX, INC.
Common Stock Warrant (right to buy)
P - Purchase 420.561 420.561 0,12 52.570 52.570
2015-06-09 2015-06-05 4 ARDX ARDELYX, INC.
Common Stock Warrant (right to buy)
P - Purchase 560.748 560.748 0,12 70.094 70.094
2015-06-09 2015-06-05 4 ARDX ARDELYX, INC.
Common Stock
P - Purchase 1.401.869 1.401.869 10,70 14.999.998 14.999.998
2015-06-09 2015-06-05 4 ARDX ARDELYX, INC.
Common Stock
P - Purchase 1.401.869 1.401.869 10,70 14.999.998 14.999.998
2015-06-09 2015-06-05 4 ARDX ARDELYX, INC.
Common Stock
P - Purchase 1.869.159 7.488.893 33,26 10,70 20.000.001 80.131.155
2015-06-04 2015-06-03 4 TSRO TESARO, Inc.
Common Stock
S - Sale -110 0 -100,00 58,43 -6.427
2015-06-04 2015-06-03 4 TSRO TESARO, Inc.
Common Stock
S - Sale -110 0 -100,00 58,38 -6.422
2015-06-04 2015-06-02 4 TSRO TESARO, Inc.
Common Stock
S - Sale -64 110 -36,78 59,72 -3.822 6.569
2015-06-04 2015-06-02 4 TSRO TESARO, Inc.
Common Stock
S - Sale -64 8.854.740 0,00 59,72 -3.822 528.805.073
2015-06-02 2015-06-01 4 TSRO TESARO, Inc.
Common Stock
J - Other 64 174 58,18
2015-06-02 2015-06-01 4 TSRO TESARO, Inc.
Common Stock
J - Other 64 174 58,18
2015-06-02 2015-06-01 4 TSRO TESARO, Inc.
Common Stock
J - Other 375 375
2015-06-02 2015-06-01 4 TSRO TESARO, Inc.
Common Stock
J - Other -10.000 0 -100,00
2015-06-02 2015-06-01 4 TSRO TESARO, Inc.
Common Stock
J - Other 10.000 10.000
2015-06-02 2015-06-01 4 TSRO TESARO, Inc.
Common Stock
J - Other -1.000.000 8.854.255 -10,15
2015-05-29 2015-05-27 4 HIVE AEROHIVE NETWORKS, INC
Common Stock
A - Award 23.295 41.580 127,40
2015-05-11 2015-05-07 4 HPTX HYPERION THERAPEUTICS INC
Common Stock
U - Other -2.384.221 0 -100,00 46,00 -109.674.166
2015-03-24 3 CSBR CHAMPIONS ONCOLOGY, INC.
Common Stock
37.500.000
2015-03-24 3 CSBR CHAMPIONS ONCOLOGY, INC.
Common Stock
37.500.000
2015-02-05 2015-02-04 4 TCON Tracon Pharmaceuticals, Inc.
Series B Redeemable Convertible Preferred Stock
C - Conversion -5.373.396 0 -100,00
2015-02-05 2015-02-04 4 TCON Tracon Pharmaceuticals, Inc.
Common Stock
P - Purchase 500.000 1.888.474 36,01 10,00 5.000.000 18.884.740
2015-02-05 2015-02-04 4 TCON Tracon Pharmaceuticals, Inc.
Common Stock
C - Conversion 1.388.474 1.388.474
2015-02-02 2015-01-30 4 ZSAN Zosano Pharma Corp
8% Convertible Note Issued 9/9/2013
C - Conversion
2015-02-02 2015-01-30 4 ZSAN Zosano Pharma Corp
8% Convertible Note Issued 12/2/2014
C - Conversion
2015-02-02 2015-01-30 4 ZSAN Zosano Pharma Corp
8% Convertible Note Issued 2/26/14
C - Conversion
2015-02-02 2015-01-30 4 ZSAN Zosano Pharma Corp
Common Stock
P - Purchase 23.457 2.158.539 1,10 11,00 258.027 23.743.929
2015-02-02 2015-01-30 4 ZSAN Zosano Pharma Corp
Common Stock
C - Conversion 341.201 2.135.082 19,02 9,35 3.190.229 19.963.017
2015-01-29 2015-01-28 4 BOX BOX INC
Class B Common Stock
J - Other 2.091.457 2.091.457
2015-01-29 2015-01-28 4 BOX BOX INC
Series E Preferred Stock
C - Conversion -274.916 0 -100,00
2015-01-29 2015-01-28 4 BOX BOX INC
Series D2 Preferred Stock
C - Conversion -1.653.761 0 -100,00
2015-01-29 2015-01-28 4 BOX BOX INC
Existing Class A Common Stock
J - Other -2.091.457 0 -100,00
2015-01-29 2015-01-28 4 BOX BOX INC
Existing Class A Common Stock
C - Conversion 1.928.677 2.091.457 1.184,84
2015-01-26 3 ZSAN Zosano Pharma Corp
Common Stock
3.587.762
2015-01-26 3 ZSAN Zosano Pharma Corp
Common Stock
3.587.762
2015-01-26 3 ZSAN Zosano Pharma Corp
Common Stock
3.587.762
2015-01-26 3 ZSAN Zosano Pharma Corp
Common Stock
3.587.762
2015-01-26 3 ZSAN Zosano Pharma Corp
Common Stock
3.587.762
2015-01-26 3 ZSAN Zosano Pharma Corp
Common Stock
3.587.762
2015-01-26 3 ZSAN Zosano Pharma Corp
Common Stock
3.587.762
2015-01-26 3 ZSAN Zosano Pharma Corp
Common Stock
3.587.762
2015-01-26 3 ZSAN Zosano Pharma Corp
Common Stock
3.587.762
2015-01-26 3 ZSAN Zosano Pharma Corp
Common Stock
3.587.762
2015-01-22 3 BOX BOX INC
Existing Class A Common Stock
325.560
2015-01-22 3 BOX BOX INC
Existing Class A Common Stock
325.560
2014-12-29 2014-12-23 4 ARDX ARDELYX, INC.
Common Stock
J - Other -10.000 0 -100,00
2014-12-29 2014-12-23 4 ILIU INTERLEUKIN GENETICS INC
Common Stock Warrant (right to buy)
P - Purchase 19.868.965 19.868.965
2014-12-29 2014-12-23 4 ILIU INTERLEUKIN GENETICS INC
Common Stock
P - Purchase 19.868.965 35.298.087 128,78 0,10 1.992.857 3.540.398
2014-12-29 2014-12-29 4 ARDX ARDELYX, INC.
Common Stock
S - Sale -22 0 -100,00 20,09 -442
2014-12-29 2014-12-29 4 ARDX ARDELYX, INC.
Common Stock
S - Sale -22 5.619.734 0,00 20,09 -442 112.895.398
2014-12-29 2014-12-29 4 ARDX ARDELYX, INC.
Common Stock
S - Sale -223 0 -100,00 20,09 -4.480
2014-12-29 2014-12-23 4 ARDX ARDELYX, INC.
Common Stock
J - Other 22 22
2014-12-29 2014-12-23 4 ARDX ARDELYX, INC.
Common Stock
J - Other 22 5.619.756 0,00
2014-12-29 2014-12-23 4 ARDX ARDELYX, INC.
Common Stock
J - Other 223 223
2014-12-29 2014-12-23 4 ARDX ARDELYX, INC.
Common Stock
J - Other -10.000 0 -100,00
2014-12-16 2014-12-12 4 ARDX ARDELYX, INC.
Common Stock
J - Other -1.000.000 5.619.734 -15,11
2014-12-10 2014-12-10 4 TRVN TREVENA INC
Common Stock
P - Purchase 1.000.000 4.811.691 26,24 4,00 4.000.000 19.246.764
2014-12-04 2014-12-02 4 DATA Tableau Software Inc
Class B Common Stock
C - Conversion -1.250.000 1.964.192 -38,89
2014-12-04 2014-12-02 4 DATA Tableau Software Inc
Class A Common Stock
J - Other 3.373 3.767 856,09
2014-12-04 2014-12-02 4 DATA Tableau Software Inc
Class A Common Stock
J - Other 394 394
2014-12-04 2014-12-02 4 DATA Tableau Software Inc
Class A Common Stock
J - Other -383.750 0 -100,00
2014-12-04 2014-12-02 4 DATA Tableau Software Inc
Class A Common Stock
J - Other 383.750 383.750
2014-12-04 2014-12-02 4 DATA Tableau Software Inc
Class A Common Stock
J - Other -1.250.000 0 -100,00
2014-12-04 2014-12-02 4 DATA Tableau Software Inc
Class A Common Stock
C - Conversion 1.250.000 1.250.000
2014-11-28 2014-11-25 4 CVT CVENT INC
Common Stock
J - Other 65 65
2014-11-28 2014-11-25 4 CVT CVENT INC
Common Stock
J - Other 65 65
2014-11-28 2014-11-25 4 CVT CVENT INC
Common Stock
J - Other 375 375
2014-11-28 2014-11-25 4 CVT CVENT INC
Common Stock
J - Other -10.000 0 -100,00
2014-11-28 2014-11-25 4 CVT CVENT INC
Common Stock
J - Other 10.000 10.000
2014-11-28 2014-11-25 4 CVT CVENT INC
Common Stock
J - Other -1.000.000 3.994.106 -20,02
2014-10-08 2014-10-08 4 DERM Dermira, Inc.
Series C Preferred Stock
C - Conversion -382.840 0 -100,00
2014-10-08 2014-10-08 4 DERM Dermira, Inc.
Series B Preferred Stock
C - Conversion -655.321 0 -100,00
2014-10-08 2014-10-08 4 DERM Dermira, Inc.
Series A Preferred Stock
C - Conversion -2.378.408 0 -100,00
2014-10-08 2014-10-08 4 DERM Dermira, Inc.
Common Stock
P - Purchase 69.112 3.502.922 2,01 16,00 1.105.792 56.046.752
2014-10-08 2014-10-08 4 DERM Dermira, Inc.
Common Stock
C - Conversion 3.416.569 3.433.810 19.816,54
2014-10-02 3 DERM Dermira, Inc.
Common Stock
34.482
2014-10-02 3 DERM Dermira, Inc.
Common Stock
34.482
2014-08-29 2014-08-29 4 SNSS SUNESIS PHARMACEUTICALS INC
Common Stock
S - Sale -11.600 4.659.333 -0,25 7,51 -87.070 34.972.953
2014-08-29 2014-08-28 4 SNSS SUNESIS PHARMACEUTICALS INC
Common Stock
S - Sale -146.800 4.670.933 -3,05 7,87 -1.154.846 36.745.296
2014-08-29 2014-08-27 4 SNSS SUNESIS PHARMACEUTICALS INC
Common Stock
S - Sale -108.300 4.817.733 -2,20 8,17 -884.811 39.360.879
2014-08-22 2014-08-22 4 DATA Tableau Software Inc
Class A Common Stock
S - Sale -4.842 0 -100,00 60,32 -292.073
2014-08-22 2014-08-20 4 DATA Tableau Software Inc
Class B Common Stock
C - Conversion -1.607.096 3.214.192 -33,33
2014-08-22 2014-08-20 4 DATA Tableau Software Inc
Class A Common Stock
J - Other 4.336 4.842 856,92
2014-08-22 2014-08-20 4 DATA Tableau Software Inc
Class A Common Stock
J - Other 506 506
2014-08-22 2014-08-20 4 DATA Tableau Software Inc
Class A Common Stock
J - Other -493.378 0 -100,00
2014-08-22 2014-08-20 4 DATA Tableau Software Inc
Class A Common Stock
J - Other 493.378 493.378
2014-08-22 2014-08-20 4 DATA Tableau Software Inc
Class A Common Stock
J - Other -1.607.096 0 -100,00
2014-08-22 2014-08-20 4 DATA Tableau Software Inc
Class A Common Stock
C - Conversion 1.607.096 1.607.096
2014-08-18 2014-08-15 4 EPZM Epizyme, Inc.
Common Stock
S - Sale -84 0 -100,00 36,57 -3.072
2014-08-18 2014-08-15 4 EPZM Epizyme, Inc.
Common Stock
S - Sale -84 0 -100,00 36,57 -3.072
2014-08-18 2014-08-15 4 EPZM Epizyme, Inc.
Common Stock
S - Sale -483 0 -100,00 36,57 -17.663
2014-08-18 2014-08-14 4 EPZM Epizyme, Inc.
Common Stock
J - Other 84 84
2014-08-18 2014-08-14 4 EPZM Epizyme, Inc.
Common Stock
J - Other 84 84
2014-08-18 2014-08-14 4 EPZM Epizyme, Inc.
Common Stock
J - Other 483 483
2014-08-18 2014-08-14 4 EPZM Epizyme, Inc.
Common Stock
J - Other -12.900 0 -100,00
2014-08-18 2014-08-14 4 EPZM Epizyme, Inc.
Common Stock
J - Other 12.900 12.900
2014-08-18 2014-08-14 4 EPZM Epizyme, Inc.
Common Stock
J - Other -1.290.000 4.743.240 -21,38
2014-08-18 2014-08-15 4 EPZM Epizyme, Inc.
Common Stock
S - Sale -84 0 -100,00 36,57 -3.072
2014-08-18 2014-08-15 4 EPZM Epizyme, Inc.
Common Stock
S - Sale -84 406.500 -0,02 36,57 -3.072 14.865.705
2014-08-18 2014-08-15 4 EPZM Epizyme, Inc.
Common Stock
S - Sale -483 0 -100,00 36,57 -17.663
2014-08-18 2014-08-14 4 EPZM Epizyme, Inc.
Common Stock
J - Other 84 84
2014-08-18 2014-08-14 4 EPZM Epizyme, Inc.
Common Stock
J - Other 84 406.584 0,02
2014-08-18 2014-08-14 4 EPZM Epizyme, Inc.
Common Stock
J - Other 483 483
2014-08-18 2014-08-14 4 EPZM Epizyme, Inc.
Common Stock
J - Other -12.900 0 -100,00
2014-08-18 2014-08-14 4 EPZM Epizyme, Inc.
Common Stock
J - Other 12.900 12.900
2014-08-18 2014-08-14 4 EPZM Epizyme, Inc.
Common Stock
J - Other -1.290.000 4.743.240 -21,38
2014-08-18 2014-08-15 4 CVT CVENT INC
Common Stock
S - Sale -65 0 -100,00 26,27 -1.708
2014-08-18 2014-08-15 4 CVT CVENT INC
Common Stock
S - Sale -65 0 -100,00 26,27 -1.708
2014-08-18 2014-08-15 4 CVT CVENT INC
Common Stock
S - Sale -374 0 -100,00 26,27 -9.825
2014-08-18 2014-08-14 4 CVT CVENT INC
Common Stock
J - Other 65 65
2014-08-18 2014-08-14 4 CVT CVENT INC
Common Stock
J - Other 65 65
2014-08-18 2014-08-14 4 CVT CVENT INC
Common Stock
J - Other 374 374
2014-08-18 2014-08-14 4 CVT CVENT INC
Common Stock
J - Other -10.000 0 -100,00
2014-08-18 2014-08-14 4 CVT CVENT INC
Common Stock
J - Other 10.000 10.000
2014-08-18 2014-08-14 4 CVT CVENT INC
Common Stock
J - Other -1.000.000 4.994.106 -16,68
2014-08-12 2014-08-12 4 SNSS SUNESIS PHARMACEUTICALS INC
Common Stock
S - Sale -35.540 4.926.033 -0,72 6,76 -240.190 33.291.609
2014-08-12 2014-08-08 4 SNSS SUNESIS PHARMACEUTICALS INC
Common Stock
S - Sale -675.000 4.961.573 -11,98 6,62 -4.468.568 32.846.109
2014-08-06 2014-08-06 4 LOXO Loxo Oncology, Inc.
Series B Convertible Preferred Stock
C - Conversion -1.558.651 0 -100,00
2014-08-06 2014-08-06 4 LOXO Loxo Oncology, Inc.
Common Stock
P - Purchase 230.769 1.789.420 14,81 13,00 2.999.997 23.262.460
2014-08-06 2014-08-06 4 LOXO Loxo Oncology, Inc.
Common Stock
C - Conversion 1.558.651 1.558.651
2014-07-22 2014-07-22 4 ROKA Roka BioScience, Inc.
Series E Preferred Stock
C - Conversion -5.987.892 0 -100,00
2014-07-22 2014-07-22 4 ROKA Roka BioScience, Inc.
Series D Preferred Stock
C - Conversion -8.555.784 0 -100,00
2014-07-22 2014-07-22 4 ROKA Roka BioScience, Inc.
Series C Preferred Stock
C - Conversion -4.030.224 0 -100,00
2014-07-22 2014-07-22 4 ROKA Roka BioScience, Inc.
Series B Preferred Stock
C - Conversion -12.360.000 0 -100,00
2014-07-22 2014-07-22 4 ROKA Roka BioScience, Inc.
Common Stock
P - Purchase 383.333 3.216.810 13,53 12,00 4.599.996 38.601.720
2014-07-22 2014-07-22 4 ROKA Roka BioScience, Inc.
Common Stock
C - Conversion 542.381 2.833.477 23,67
2014-07-22 2014-07-22 4 ROKA Roka BioScience, Inc.
Common Stock
C - Conversion 801.741 2.291.096 53,83
2014-07-22 2014-07-22 4 ROKA Roka BioScience, Inc.
Common Stock
C - Conversion 365.056 1.489.355 32,47
2014-07-22 2014-07-22 4 ROKA Roka BioScience, Inc.
Common Stock
C - Conversion 1.119.565 1.124.299 23.649,45
2014-07-16 3 ROKA Roka BioScience, Inc.
Common Stock
9.468
2014-07-16 3 ROKA Roka BioScience, Inc.
Common Stock
9.468
2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Series B Preferred Stock
C - Conversion -72.190 0 -100,00
2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Series B Preferred Stock
J - Other -468 72.190 -0,64 14,00 -6.552 1.010.660
2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Series B Preferred Stock
X - Other 72.658 72.658
2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Series B Preferred Stock Purchase Warrant
X - Other -72.658 0 -100,00
2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Series B Preferred Stock
C - Conversion -216.573 0 -100,00
2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Series B Preferred Stock
J - Other -1.402 216.573 -0,64 14,00 -19.628 3.032.022
2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Series B Preferred Stock
X - Other 217.975 217.975
2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Series B Preferred Stock Purchase Warrant
X - Other -217.975 0 -100,00
2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Series B Preferred Stock
C - Conversion -4.404.887 0 -100,00
2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Series A Preferred Stock
C - Conversion -1.415.642 0 -100,00
2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Common Stock
P - Purchase 510.442 6.619.734 8,36 14,00 7.146.188 92.676.276
2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Common Stock
C - Conversion 72.190 6.109.292 1,20
2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Common Stock
C - Conversion 216.573 6.037.102 3,72
2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Common Stock
C - Conversion 4.404.887 5.820.529 311,16
2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Common Stock
C - Conversion 1.415.642 1.415.642
2014-06-20 2014-06-18 4 HIVE AEROHIVE NETWORKS, INC
Common Stock
A - Award 18.285 18.285
2014-06-06 2014-06-06 4 HPTX HYPERION THERAPEUTICS INC
Common Stock
S - Sale -10 0 -100,00 27,19 -272
2014-06-06 2014-06-06 4 HPTX HYPERION THERAPEUTICS INC
Common Stock
S - Sale -10 0 -100,00 27,19 -272
2014-06-06 2014-06-06 4 HPTX HYPERION THERAPEUTICS INC
Common Stock
S - Sale -100 0 -100,00 27,19 -2.719
2014-06-06 2014-06-05 4 HPTX HYPERION THERAPEUTICS INC
Common Stock
J - Other 10 10
2014-06-06 2014-06-05 4 HPTX HYPERION THERAPEUTICS INC
Common Stock
J - Other 10 10
2014-06-06 2014-06-05 4 HPTX HYPERION THERAPEUTICS INC
Common Stock
J - Other 100 100
2014-06-06 2014-06-05 4 HPTX HYPERION THERAPEUTICS INC
Common Stock
J - Other -5.000 0 -100,00
2014-06-06 2014-06-05 4 HPTX HYPERION THERAPEUTICS INC
Common Stock
J - Other 5.000 5.000
2014-06-06 2014-06-05 4 HPTX HYPERION THERAPEUTICS INC
Common Stock
J - Other -500.000 2.384.221 -17,34
2014-05-15 2014-05-14 4 DATA Tableau Software Inc
Class A Common Stock
S - Sale -1.518 0 -100,00 53,92 -81.846
2014-05-12 2014-04-09 4 DATA Tableau Software Inc
Class A Common Stock
G - Gift -8.167 1.518 -84,33
2014-04-24 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Warrant to Purchase Common Stock (right to buy)
C - Conversion 55.831 55.831
2014-04-24 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Warrant to Purchase Series D Preferred Stock (right to buy)
C - Conversion -55.831 0 -100,00 15,81 -882.470
2014-04-24 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Series E Preferred Stock
C - Conversion -411.234 0 -100,00
2014-04-24 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Series D Preferred Stock
C - Conversion -1.236.487 0 -100,00
2014-04-24 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Series C Preferred Stock
C - Conversion -531.758 0 -100,00
2014-04-24 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Series B Preferred Stock
C - Conversion -383.249 0 -100,00
2014-04-24 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Series A Preferred Stock
C - Conversion -797.208 0 -100,00
2014-04-24 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Common Stock
C - Conversion 411.234 3.943.269 11,64
2014-04-24 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Common Stock
C - Conversion 1.236.487 3.532.035 53,86
2014-04-24 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Common Stock
C - Conversion 531.758 2.295.548 30,15
2014-04-24 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Common Stock
C - Conversion 383.249 1.763.790 27,76
2014-04-24 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Common Stock
C - Conversion 797.208 1.380.541 136,66
2014-04-24 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Common Stock
P - Purchase 583.333 583.333 12,00 6.999.996 6.999.996
2014-04-09 2014-04-09 4 OPWR OPOWER, INC.
Series C Preferred Stock
C - Conversion -1.123.596 0 -100,00
2014-04-09 2014-04-09 4 OPWR OPOWER, INC.
Series B Preferred Stock
C - Conversion -7.866.170 0 -100,00
2014-04-09 2014-04-09 4 OPWR OPOWER, INC.
Common Stock
C - Conversion 8.989.766 8.989.766
2014-04-03 2014-04-02 4 HIVE AEROHIVE NETWORKS, INC
Series E Preferred Stock
C - Conversion -1.065.143 0 -100,00
2014-04-03 2014-04-02 4 HIVE AEROHIVE NETWORKS, INC
Series D Preferred Stock
C - Conversion -3.588.446 0 -100,00
2014-04-03 2014-04-02 4 HIVE AEROHIVE NETWORKS, INC
Common Stock
C - Conversion 4.653.589 4.673.589 23.267,94
2014-03-27 3 HIVE AEROHIVE NETWORKS, INC
Common Stock
40.000
2014-03-27 3 HIVE AEROHIVE NETWORKS, INC
Common Stock
40.000
2014-03-05 2014-03-05 4 DATA Tableau Software Inc
Class A Common Stock
S - Sale -800 9.685 -7,63 95,35 -76.280 923.471
2014-03-05 2014-03-05 4 DATA Tableau Software Inc
Class A Common Stock
S - Sale -4.043 10.485 -27,83 94,43 -381.773 990.079
2014-03-05 2014-03-04 4 DATA Tableau Software Inc
Class B Common Stock
C - Conversion -1.607.096 4.821.288 -25,00
2014-03-05 2014-03-04 4 DATA Tableau Software Inc
Class A Common Stock
J - Other 4.337 14.528 42,56
2014-03-05 2014-03-04 4 DATA Tableau Software Inc
Class A Common Stock
J - Other 506 10.191 5,22
2014-03-05 2014-03-04 4 DATA Tableau Software Inc
Class A Common Stock
J - Other -493.378 0 -100,00
2014-03-05 2014-03-04 4 DATA Tableau Software Inc
Class A Common Stock
J - Other 493.378 493.378
2014-03-05 2014-03-04 4 DATA Tableau Software Inc
Class A Common Stock
J - Other -1.607.096 0 -100,00
2014-03-05 2014-03-04 4 DATA Tableau Software Inc
Class A Common Stock
C - Conversion 1.607.096 1.607.096
2014-02-28 2014-02-26 4 DATA Tableau Software Inc
Class B Common Stock
C - Conversion -3.214.192 6.428.384 -33,33
2014-02-28 2014-02-26 4 DATA Tableau Software Inc
Class A Common Stock
J - Other 8.673 9.685 857,02
2014-02-28 2014-02-26 4 DATA Tableau Software Inc
Class A Common Stock
J - Other 1.012 1.012
2014-02-28 2014-02-26 4 DATA Tableau Software Inc
Class A Common Stock
J - Other -986.757 0 -100,00
2014-02-28 2014-02-26 4 DATA Tableau Software Inc
Class A Common Stock
J - Other 986.757 986.757
2014-02-28 2014-02-26 4 DATA Tableau Software Inc
Class A Common Stock
J - Other -3.214.192 0 -100,00
2014-02-28 2014-02-26 4 DATA Tableau Software Inc
Class A Common Stock
C - Conversion 3.214.192 3.214.192
2014-02-07 2014-02-05 4 TRVN TREVENA INC
Series C Preferred Stock
C - Conversion -4.840.686 0 -100,00
2014-02-07 2014-02-05 4 TRVN TREVENA INC
Series B-1 Preferred Stock
C - Conversion -1.462.857 0 -100,00
2014-02-07 2014-02-05 4 TRVN TREVENA INC
Series B-1 Preferred Stock
S - Sale -487.143 1.462.857 -24,98 1,13 -549.984 1.651.566
2014-02-07 2014-02-05 4 TRVN TREVENA INC
Series B-1 Preferred Stock
X - Other 550.000 1.950.000 39,29 1,00 550.000 1.950.000
2014-02-07 2014-02-05 4 TRVN TREVENA INC
Series B-1 Warrants
X - Other -550.000 0 -100,00
2014-02-07 2014-02-05 4 TRVN TREVENA INC
Series B Preferred Stock
C - Conversion -8.400.000 0 -100,00
2014-02-07 2014-02-05 4 TRVN TREVENA INC
Series A Preferred Stock
C - Conversion -6.000.000 0 -100,00
2014-02-07 2014-02-05 4 TRVN TREVENA INC
Common Stock
P - Purchase 472.410 3.811.691 14,15 7,00 3.306.870 26.681.837
2014-02-07 2014-02-05 4 TRVN TREVENA INC
Common Stock
C - Conversion 3.339.281 3.339.281
2014-01-29 2014-01-29 4 CRCM Care.com Inc
Series E Convertible Preferred Stock
C - Conversion -612.089 0 -100,00
2014-01-29 2014-01-29 4 CRCM Care.com Inc
Series D Convertible Preferred Stock
C - Conversion -401.837 0 -100,00
2014-01-29 2014-01-29 4 CRCM Care.com Inc
Series C Convertible Preferred Stock
C - Conversion -2.242.087 0 -100,00
2014-01-29 2014-01-29 4 CRCM Care.com Inc
Common Stock
C - Conversion 612.089 3.256.013 23,15
2014-01-29 2014-01-29 4 CRCM Care.com Inc
Common Stock
C - Conversion 401.837 2.643.924 17,92
2014-01-29 2014-01-29 4 CRCM Care.com Inc
Common Stock
C - Conversion 2.242.087 2.242.087
2014-01-28 2014-01-27 4 ECOM CHANNELADVISOR CORP
Common Stock Warrant (right to buy)
X - Other -56.983 0 -100,00
2014-01-28 2014-01-27 4 ECOM CHANNELADVISOR CORP
Common Stock Warrant (right to buy)
X - Other -160.672 0 -100,00
2014-01-28 2014-01-27 4 ECOM CHANNELADVISOR CORP
Common Stock Warrant (right to buy)
X - Other -749.721 0 -100,00
2014-01-28 2014-01-27 4 ECOM CHANNELADVISOR CORP
Common Stock
D - Sale to Issuer -13.551 2.316.692 -0,58 10,96 -148.519 25.390.944
2014-01-28 2014-01-27 4 ECOM CHANNELADVISOR CORP
Common Stock
X - Other 56.983 2.330.243 2,51 10,96 624.534 25.539.463
2014-01-28 2014-01-27 4 ECOM CHANNELADVISOR CORP
Common Stock
D - Sale to Issuer -38.210 2.273.260 -1,65 10,96 -418.782 24.914.930
2014-01-28 2014-01-27 4 ECOM CHANNELADVISOR CORP
Common Stock
X - Other 160.672 2.311.470 7,47 10,96 1.760.965 25.333.711
2014-01-28 2014-01-27 4 ECOM CHANNELADVISOR CORP
Common Stock
D - Sale to Issuer -260.280 2.150.798 -10,80 16,00 -4.164.480 34.412.768
2014-01-28 2014-01-27 4 ECOM CHANNELADVISOR CORP
Common Stock
X - Other 749.721 2.411.078 45,13 16,00 11.995.536 38.577.248
2014-01-23 2014-01-21 4 CVT CVENT INC
Common Stock
S - Sale -169.887 5.994.106 -2,76 35,50 -6.030.988 212.790.763
2014-01-21 2014-01-16 4 CVT CVENT INC
Common Stock
S - Sale -1.132.589 6.163.993 -15,52 35,50 -40.206.910 218.821.752
2014-01-15 2014-01-15 4 GLYC GLYCOMIMETICS INC
Series A-1 Preferred Stock
C - Conversion -11.824.058 0 -100,00
2014-01-15 2014-01-15 4 GLYC GLYCOMIMETICS INC
Common Stock
P - Purchase 512.500 4.093.377 14,31 8,00 4.100.000 32.747.016
2014-01-15 2014-01-15 4 GLYC GLYCOMIMETICS INC
Common Stock
C - Conversion 3.580.877 3.580.877
2013-12-16 2013-03-13 4 ADNC AUDIENCE INC
Common Stock
G - Gift -757 0 -100,00
2013-11-20 2013-11-20 4 DATA Tableau Software Inc
Class B Common Stock
C - Conversion -1.152.625 9.642.576 -10,68
2013-11-20 2013-11-20 4 DATA Tableau Software Inc
Class A Common Stock
S - Sale -1.152.625 0 -100,00 62,72 -72.298.403
2013-11-20 2013-11-20 4 DATA Tableau Software Inc
Class A Common Stock
C - Conversion 1.152.625 1.152.625
2013-11-18 2013-11-15 4 EPZM Epizyme, Inc.
Common Stock
P - Purchase 25.800 406.500 6,78 19,31 498.185 7.849.312
2013-11-18 2013-11-15 4 EPZM Epizyme, Inc.
Common Stock
P - Purchase 23.700 380.700 6,64 20,31 481.269 7.730.761
2013-11-18 2013-11-14 4 EPZM Epizyme, Inc.
Common Stock
P - Purchase 163.620 357.000 84,61 19,04 3.115.538 6.797.744
2013-11-18 2013-11-14 4 EPZM Epizyme, Inc.
Common Stock
P - Purchase 152.459 193.380 372,57 19,99 3.047.335 3.865.260
2013-11-18 2013-11-14 4 EPZM Epizyme, Inc.
Common Stock
P - Purchase 40.921 40.921 20,91 855.654 855.654
2013-11-14 2013-11-13 4 DATA Tableau Software Inc
Class B Common Stock
C - Conversion -6.756.077 10.795.201 -38,49
2013-11-14 2013-11-13 4 DATA Tableau Software Inc
Class A Common Stock
S - Sale -6.756.077 0 -100,00 62,72 -423.774.930
2013-11-14 2013-11-13 4 DATA Tableau Software Inc
Class A Common Stock
C - Conversion 6.756.077 6.756.077
2013-11-13 2013-11-12 4 ECOM CHANNELADVISOR CORP
Common Stock
S - Sale -201.012 1.661.357 -10,79 32,37 -6.506.758 53.778.126
2013-11-13 2013-11-12 4 ECOM CHANNELADVISOR CORP
Common Stock
S - Sale -903.229 1.862.369 -32,66 32,37 -29.237.523 60.284.885
2013-11-06 2013-11-04 4 ADNC AUDIENCE INC
Common Stock
J - Other 126 1.531 8,97
2013-11-06 2013-11-04 4 ADNC AUDIENCE INC
Common Stock
J - Other 648 1.405 85,60
2013-11-06 2013-11-04 4 ADNC AUDIENCE INC
Common Stock
J - Other -14.390 0 -100,00
2013-11-06 2013-11-04 4 ADNC AUDIENCE INC
Common Stock
J - Other 14.390 14.390
2013-11-06 2013-11-04 4 ADNC AUDIENCE INC
Common Stock
J - Other -1.439.003 1.439.002 -50,00
2013-10-31 2013-10-29 4 XOOM XOOM Corp
Common Stock
J - Other 1.008 1.205 511,68
2013-10-31 2013-10-29 4 XOOM XOOM Corp
Common Stock
J - Other 197 197
2013-10-31 2013-10-29 4 XOOM XOOM Corp
Common Stock
J - Other -22.394 0 -100,00
2013-10-31 2013-10-29 4 XOOM XOOM Corp
Common Stock
J - Other 22.394 22.394
2013-10-31 2013-10-29 4 XOOM XOOM Corp
Common Stock
J - Other -2.239.385 2.239.385 -50,00
2013-09-18 2013-09-05 4 GRPN Groupon, Inc.
Class A Common Stock
G - Gift -2.610 4.016 -39,39
2013-09-17 2013-09-13 4 GRPN Groupon, Inc.
Class A Common Stock
J - Other 400 400
2013-09-17 2013-09-13 4 GRPN Groupon, Inc.
Class A Common Stock
J - Other 400 400
2013-09-17 2013-09-13 4 GRPN Groupon, Inc.
Class A Common Stock
J - Other 4.016 6.626 153,87
2013-09-17 2013-09-13 4 GRPN Groupon, Inc.
Class A Common Stock
J - Other -200.000 0 -100,00
2013-09-17 2013-09-13 4 GRPN Groupon, Inc.
Class A Common Stock
J - Other 200.000 200.000
2013-09-17 2013-09-13 4 GRPN Groupon, Inc.
Class A Common Stock
J - Other -20.000.000 54.184.956 -26,96
2013-09-12 2013-09-11 4 GRPN Groupon, Inc.
Class A Common Stock
S - Sale -260 0 -100,00 11,40 -2.965
2013-09-12 2013-09-11 4 GRPN Groupon, Inc.
Class A Common Stock
S - Sale -260 0 -100,00 11,40 -2.964
2013-08-16 2013-08-14 4 GRPN Groupon, Inc.
Class A Common Stock
J - Other 260 260
2013-08-16 2013-08-14 4 GRPN Groupon, Inc.
Class A Common Stock
J - Other 260 260
2013-08-16 2013-08-14 4 GRPN Groupon, Inc.
Class A Common Stock
J - Other 2.610 2.610
2013-08-16 2013-08-14 4 GRPN Groupon, Inc.
Class A Common Stock
J - Other -130.000 0 -100,00
2013-08-16 2013-08-14 4 GRPN Groupon, Inc.
Class A Common Stock
J - Other 130.000 130.000
2013-08-16 2013-08-14 4 GRPN Groupon, Inc.
Class A Common Stock
J - Other -13.000.000 74.184.956 -14,91
2013-08-14 2013-08-14 4 CVT CVENT INC
Series A Preferred Stock
C - Conversion -7.296.582 0 -100,00
2013-08-14 2013-08-14 4 CVT CVENT INC
Common Stock
C - Conversion 7.296.582 7.296.582
2013-07-25 2013-06-27 4 TSRO TESARO, Inc.
Common Stock
G - Gift -610 0 -100,00
2013-07-18 2013-07-18 4 OMTH Omthera Pharmaceuticals, Inc.
Common Stock
D - Sale to Issuer -5.833.213 0 -100,00
2013-06-07 2013-06-05 4 EPZM Epizyme, Inc.
Series B Preferred Stock
C - Conversion -16.899.721 0 -100,00
2013-06-07 2013-06-05 4 EPZM Epizyme, Inc.
Common Stock
P - Purchase 400.000 6.033.240 7,10 15,00 6.000.000 90.498.600
2013-06-07 2013-06-05 4 EPZM Epizyme, Inc.
Common Stock
C - Conversion 5.633.240 5.633.240
2013-06-05 2013-06-04 4 TSRO TESARO, Inc.
Common Stock
J - Other 110 110
2013-06-05 2013-06-04 4 TSRO TESARO, Inc.
Common Stock
J - Other 110 110
2013-06-05 2013-06-04 4 TSRO TESARO, Inc.
Common Stock
J - Other 610 610
2013-06-05 2013-06-04 4 TSRO TESARO, Inc.
Common Stock
J - Other -16.450 0 -100,00
2013-06-05 2013-06-04 4 TSRO TESARO, Inc.
Common Stock
J - Other 16.450 16.450
2013-06-05 2013-06-04 4 TSRO TESARO, Inc.
Common Stock
J - Other -1.645.000 9.854.255 -14,31
2013-06-05 2013-06-03 4 CLVS Clovis Oncology, Inc.
Common Stock
J - Other 77 77
2013-06-05 2013-06-03 4 CLVS Clovis Oncology, Inc.
Common Stock
J - Other 77 77
2013-06-05 2013-06-03 4 CLVS Clovis Oncology, Inc.
Common Stock
J - Other 421 421
2013-06-05 2013-06-03 4 CLVS Clovis Oncology, Inc.
Common Stock
J - Other -11.399 0 -100,00
2013-06-05 2013-06-03 4 CLVS Clovis Oncology, Inc.
Common Stock
J - Other 11.399 11.399
2013-06-05 2013-06-03 4 CLVS Clovis Oncology, Inc.
Common Stock
J - Other -1.139.890 2.279.781 -33,33
2013-05-29 2013-05-29 4 ECOM CHANNELADVISOR CORP
Series C Preferred Stock
C - Conversion -44.249.588 0 -100,00
2013-05-29 2013-05-29 4 ECOM CHANNELADVISOR CORP
Series C Preferred Stock
S - Sale -95.980 44.249.588 -0,22 0,88 -83.982 38.718.390
2013-05-29 2013-05-29 4 ECOM CHANNELADVISOR CORP
Series C Preferred Stock
X - Other 122.602 44.345.568 0,28 0,68 83.982 30.376.714
2013-05-29 2013-05-29 4 ECOM CHANNELADVISOR CORP
Warrant to Purchase Series C Preferred Stock (right to buy)
X - Other -122.602 0 -100,00
2013-05-29 2013-05-29 4 ECOM CHANNELADVISOR CORP
Common Stock
C - Conversion 2.765.599 2.765.599
2013-05-23 2013-05-22 4 DATA Tableau Software Inc
Class B Common Stock
C - Conversion -2.000.000 17.551.278 -10,23
2013-05-23 2013-05-22 4 DATA Tableau Software Inc
Class B Common Stock
C - Conversion 6.541.485 19.551.278 50,28
2013-05-23 2013-05-22 4 DATA Tableau Software Inc
Series B Preferred Stock
C - Conversion -6.541.485 0 -100,00
2013-05-23 2013-05-22 4 DATA Tableau Software Inc
Class B Common Stock
C - Conversion 10.602.127 13.009.793 440,35
2013-05-23 2013-05-22 4 DATA Tableau Software Inc
Series A Preferred Stock
C - Conversion -10.602.127 0 -100,00
2013-05-23 2013-05-22 4 DATA Tableau Software Inc
Class A Common Stock
S - Sale -2.000.000 0 -100,00 28,83 -57.660.000
2013-05-23 2013-05-22 4 DATA Tableau Software Inc
Class A Common Stock
C - Conversion 2.000.000 2.000.000
2013-05-23 3 ILIU INTERLEUKIN GENETICS INC
Common Stock
15.429.122
2013-04-17 2013-04-16 4 OMTH Omthera Pharmaceuticals, Inc.
Series B Preferred Stock
C - Conversion -6.165.747 0 -100,00
2013-04-17 2013-04-16 4 OMTH Omthera Pharmaceuticals, Inc.
Secured Convertible Promissory Note
C - Conversion -633.219 0 -100,00
2013-04-17 2013-04-16 4 OMTH Omthera Pharmaceuticals, Inc.
Warrant (right to buy)
C - Conversion -156.250 0 -100,00
2013-04-17 2013-04-16 4 OMTH Omthera Pharmaceuticals, Inc.
Common Stock
P - Purchase 625.000 5.833.213 12,00 8,00 5.000.000 46.665.704
2013-04-17 2013-04-16 4 OMTH Omthera Pharmaceuticals, Inc.
Common Stock
C - Conversion 4.418.940 5.208.213 559,87
2013-04-17 2013-04-16 4 OMTH Omthera Pharmaceuticals, Inc.
Common Stock
C - Conversion 633.219 789.273 405,77 8,00 5.065.752 6.314.184
2013-04-17 2013-04-16 4 OMTH Omthera Pharmaceuticals, Inc.
Common Stock
S - Sale -196 156.054 -0,13 8,00 -1.568 1.248.432
2013-04-17 2013-04-16 4 OMTH Omthera Pharmaceuticals, Inc.
Common Stock
C - Conversion 156.250 156.250 0,01 1.562 1.562
2013-04-11 2013-04-11 4 OMTH Omthera Pharmaceuticals, Inc.
Secured Convertible Promissory Note
A - Award 633.219 633.219
2013-04-11 2013-04-11 4 OMTH Omthera Pharmaceuticals, Inc.
Warrant (right to buy)
A - Award 156.250 156.250
2013-04-11 2013-04-10 4 WDAY Workday, Inc.
Class B Common Stock
C - Conversion -2.321.212 4.642.425 -33,33
2013-04-11 2013-04-10 4 WDAY Workday, Inc.
Class A Common Stock
J - Other 46 206 28,75
2013-04-11 2013-04-10 4 WDAY Workday, Inc.
Class A Common Stock
J - Other 46 206 28,75
2013-04-11 2013-04-10 4 WDAY Workday, Inc.
Class A Common Stock
J - Other 466 1.318 54,69
2013-04-11 2013-04-10 4 WDAY Workday, Inc.
Class A Common Stock
J - Other -23.212 0 -100,00
2013-04-11 2013-04-10 4 WDAY Workday, Inc.
Class A Common Stock
J - Other 23.212 23.212
2013-04-11 2013-04-10 4 WDAY Workday, Inc.
Class A Common Stock
J - Other -2.321.212 0 -100,00
2013-04-11 2013-04-10 4 WDAY Workday, Inc.
Class A Common Stock
C - Conversion 2.321.212 2.321.212
2013-04-11 2013-04-09 4 WDAY Workday, Inc.
Class B Common Stock
C - Conversion -2.321.212 4.642.425 -33,33
2013-04-11 2013-04-09 4 WDAY Workday, Inc.
Class A Common Stock
J - Other 160 160
2013-04-11 2013-04-09 4 WDAY Workday, Inc.
Class A Common Stock
J - Other 160 160
2013-04-11 2013-04-09 4 WDAY Workday, Inc.
Class A Common Stock
J - Other 852 852
2013-04-11 2013-04-09 4 WDAY Workday, Inc.
Class A Common Stock
J - Other -23.212 0 -100,00
2013-04-11 2013-04-09 4 WDAY Workday, Inc.
Class A Common Stock
J - Other 23.212 23.212
2013-04-11 2013-04-09 4 WDAY Workday, Inc.
Class A Common Stock
J - Other -2.321.212 0 -100,00
2013-04-11 2013-04-09 4 WDAY Workday, Inc.
Class A Common Stock
C - Conversion 2.321.212 2.321.212
2013-02-25 2013-02-21 4 XOOM XOOM Corp
Series F Convertible Preferred Stock
C - Conversion -189.966 0 -100,00
2013-02-25 2013-02-21 4 XOOM XOOM Corp
Series E Convertible Preferred Stock
C - Conversion -681.458 0 -100,00
2013-02-25 2013-02-21 4 XOOM XOOM Corp
Series D Convertible Preferred Stock
C - Conversion -848.420 0 -100,00
2013-02-25 2013-02-21 4 XOOM XOOM Corp
Series C-1 Convertible Preferred Stock
C - Conversion -502.386 0 -100,00
2013-02-25 2013-02-21 4 XOOM XOOM Corp
Series C Convertible Preferred Stock
C - Conversion -2.256.540 0 -100,00
2013-02-25 2013-02-21 4 XOOM XOOM Corp
Common Stock
C - Conversion 4.478.770 4.478.770
2013-02-20 2013-02-15 4 ADNC AUDIENCE INC
Common Stock
J - Other 127 757 20,16
2013-02-20 2013-02-15 4 ADNC AUDIENCE INC
Common Stock
J - Other 630 630
2013-02-20 2013-02-15 4 ADNC AUDIENCE INC
Common Stock
J - Other -14.000 0 -100,00
2013-02-20 2013-02-15 4 ADNC AUDIENCE INC
Common Stock
J - Other 14.000 14.000
2013-02-20 2013-02-15 4 ADNC AUDIENCE INC
Common Stock
J - Other -1.400.000 2.878.005 -32,73
2012-10-30 2012-10-29 4 MM Millennial Media Inc.
Common Stock
S - Sale -1.597.787 8.196.614 -16,31 13,44 -21.478.252 110.182.984
2012-10-18 2012-10-17 4 WDAY Workday, Inc.
Class B Common Stock
C - Conversion 6.963.636 13.927.273 100,00
2012-10-18 2012-10-17 4 WDAY Workday, Inc.
Series E Convertible Preferred Stock
C - Conversion -6.963.636 0 -100,00
2012-10-18 2012-10-17 4 WDAY Workday, Inc.
Class B Common Stock
C - Conversion 6.963.637 6.963.637
2012-10-18 2012-10-17 4 WDAY Workday, Inc.
Series E Convertible Preferred Stock
C - Conversion -6.963.637 0 -100,00
2012-09-06 2012-09-05 4 FIO FUSION-IO, INC.
Common Stock
S - Sale -64.634 0 -100,00 27,67 -1.788.494
2012-09-06 2012-09-04 4 FIO FUSION-IO, INC.
Common Stock
J - Other 1.084 1.084
2012-09-06 2012-09-04 4 FIO FUSION-IO, INC.
Common Stock
J - Other -45.000 0 -100,00
2012-09-06 2012-09-04 4 FIO FUSION-IO, INC.
Common Stock
J - Other 45.000 45.000
2012-09-06 2012-09-04 4 FIO FUSION-IO, INC.
Common Stock
J - Other -4.500.000 9.038.379 -33,24
2012-08-14 2012-07-27 4 FIO FUSION-IO, INC.
Common Stock
G - Gift -2.667 0 -100,00
2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Series C-1 Preferred Stock
C - Conversion -611.185 0 -100,00
2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Convertible Promissory Note
C - Conversion 0
2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Convertible Promissory Note
C - Conversion 0
2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Convertible Promissory Note
C - Conversion 0
2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Series C-2 Preferred Stock
C - Conversion -2.043 0 -100,00
2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Series C-2 Preferred Stock
C - Conversion -2.043 0 -100,00
2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Series C-2 Preferred Stock
J - Other -51.744 2.043 -96,20 10,00 -517.440 20.430
2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Series C-2 Preferred Stock
J - Other -51.744 2.043 -96,20 10,00 -517.440 20.430
2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Series C-2 Preferred Stock
X - Other 53.787 53.787
2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Series C-2 Preferred Stock
X - Other 53.787 53.787
2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Preferred Stock Warrant (right to buy)
X - Other -53.787 0 -100,00
2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Preferred Stock Warrant (right to buy)
X - Other -53.787 0 -100,00
2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Common Stock Warrant (right to buy)
X - Other -125.291 0 -100,00
2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Series C-2 Preferred Stock
C - Conversion -898.808 0 -100,00
2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Common Stock
P - Purchase 500.000 2.884.221 20,97 10,00 5.000.000 28.842.210
2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Common Stock
C - Conversion 177.481 2.384.221 8,04
2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Common Stock
C - Conversion 180.459 2.206.740 8,91
2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Common Stock
C - Conversion 434.096 2.026.281 27,26
2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Common Stock
C - Conversion 2.043 1.592.185 0,13
2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Common Stock
C - Conversion 2.043 1.592.185 0,13
2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Common Stock
J - Other -51.119 1.588.099 -3,12
2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Common Stock
X - Other 125.291 1.639.218 8,28
2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Common Stock
C - Conversion 898.808 1.513.927 146,12
2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Common Stock
C - Conversion 611.185 615.119 15.535,97
2012-07-25 3 HPTX HYPERION THERAPEUTICS INC
Common Stock
3.934
2012-07-03 2012-07-03 4 TSRO TESARO, Inc.
Series B Preferred Stock
C - Conversion -5.253.859 0 -100,00
2012-07-03 2012-07-03 4 TSRO TESARO, Inc.
Series A Preferred Stock
C - Conversion -5.134.285 0 -100,00
2012-07-03 2012-07-03 4 TSRO TESARO, Inc.
Common Stock
P - Purchase 1.111.111 11.499.255 10,70 13,50 14.999.998 155.239.942
2012-07-03 2012-07-03 4 TSRO TESARO, Inc.
Common Stock
C - Conversion 10.388.144 10.388.144
2012-05-16 2012-05-15 4 ADNC AUDIENCE INC
Series E Preferred Stock
C - Conversion -1.349.396 0 -100,00
2012-05-16 2012-05-15 4 ADNC AUDIENCE INC
Series D Preferred Stock
C - Conversion -1.111.435 0 -100,00
2012-05-16 2012-05-15 4 ADNC AUDIENCE INC
Series C Preferred Stock
C - Conversion -450.952 0 -100,00
2012-05-16 2012-05-15 4 ADNC AUDIENCE INC
Series B-1 Preferred Stock
C - Conversion -230.379 0 -100,00
2012-05-16 2012-05-15 4 ADNC AUDIENCE INC
Series B Preferred Stock
C - Conversion -1.135.843 0 -100,00
2012-05-16 2012-05-15 4 ADNC AUDIENCE INC
Common Stock
C - Conversion 4.278.005 4.278.005
2012-05-08 2012-05-04 4 SUPN SUPERNUS PHARMACEUTICALS INC
Series A Preferred Stock
C - Conversion -24.965.000 0 -100,00
2012-05-08 2012-05-04 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
P - Purchase 4.400.000 10.641.250 70,50 5,00 22.000.000 53.206.250
2012-05-08 2012-05-04 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
C - Conversion 6.241.250 6.241.250
2012-05-01 2012-04-27 4 FIO FUSION-IO, INC.
Common Stock
J - Other 1.688 2.667 172,42
2012-05-01 2012-04-27 4 FIO FUSION-IO, INC.
Common Stock
J - Other -69.998 0 -100,00
2012-04-04 2012-04-03 4 MM Millennial Media Inc.
Series D Preferred Stock
C - Conversion -1.758.302 0 -100,00
2012-04-04 2012-04-03 4 MM Millennial Media Inc.
Series C Preferred Stock
C - Conversion -8.036.099 0 -100,00
2012-04-04 2012-04-03 4 MM Millennial Media Inc.
Common Stock
C - Conversion 9.794.401 9.794.401
2012-03-30 2012-03-28 4 INWK INNERWORKINGS INC
Common Stock
J - Other 225 675 50,00
2012-03-30 2012-03-28 4 INWK INNERWORKINGS INC
Common Stock
J - Other 5.000 15.000 50,00
2012-03-30 2012-03-28 4 INWK INNERWORKINGS INC
Common Stock
J - Other -500.000 4.529.190 -9,94
2012-03-30 2012-03-26 4/A INWK INNERWORKINGS INC
Common Stock
J - Other 450 450
2012-03-30 2012-03-26 4/A INWK INNERWORKINGS INC
Common Stock
J - Other 10.000 10.000
2012-03-30 2012-03-26 4/A INWK INNERWORKINGS INC
Common Stock
J - Other -1.000.000 5.029.190 -16,59
2012-03-28 2012-03-26 4 INWK INNERWORKINGS INC
Common Stock
J - Other 10.000 10.000
2012-03-28 2012-03-26 4 INWK INNERWORKINGS INC
Common Stock
J - Other -1.000.000 5.029.190 -16,59
2012-03-16 2012-03-14 4 FIO FUSION-IO, INC.
Common Stock
J - Other 10.000 69.998 16,67
2012-03-16 2012-03-14 4 FIO FUSION-IO, INC.
Common Stock
J - Other -1.000.000 13.538.379 -6,88
2012-03-13 2012-03-09 4 FIO FUSION-IO, INC.
Common Stock
J - Other 9.998 59.998 20,00
2012-03-13 2012-03-09 4 FIO FUSION-IO, INC.
Common Stock
J - Other -1.000.000 14.538.379 -6,44
2012-03-09 2012-03-07 4 FOLD AMICUS THERAPEUTICS INC
Common Stock
P - Purchase 925.154 4.584.311 25,28 5,70 5.273.378 26.130.573
2012-03-07 2012-03-05 4 FIO FUSION-IO, INC.
Common Stock
J - Other 10.000 50.000 25,00
2012-03-07 2012-03-05 4 FIO FUSION-IO, INC.
Common Stock
J - Other -1.000.000 15.538.379 -6,05
2012-03-01 2012-02-28 4 ECHO Echo Global Logistics, Inc.
Common Stock
J - Other 97 97
2012-03-01 2012-02-28 4 ECHO Echo Global Logistics, Inc.
Common Stock
J - Other -4.000 0 -100,00
2012-03-01 2012-02-28 4 ECHO Echo Global Logistics, Inc.
Common Stock
J - Other 4.000 4.000
2012-03-01 2012-02-28 4 ECHO Echo Global Logistics, Inc.
Common Stock
J - Other -400.000 2.020.219 -16,53
2012-03-01 2012-02-29 4 INWK INNERWORKINGS INC
Common Stock
S - Sale -455.360 6.029.190 -7,02 11,42 -5.199.164 68.839.483
2012-02-29 2012-02-27 4 FIO FUSION-IO, INC.
Common Stock
J - Other 10.000 40.000 33,33
2012-02-29 2012-02-27 4 FIO FUSION-IO, INC.
Common Stock
J - Other -1.000.000 16.538.379 -5,70
2012-02-28 2012-02-24 4 INWK INNERWORKINGS INC
Common Stock
S - Sale -334.457 6.484.550 -4,90 11,40 -3.812.810 73.923.870
2012-02-27 2012-02-24 4 FIO FUSION-IO, INC.
Common Stock
J - Other 10.000 30.000 50,00
2012-02-27 2012-02-24 4 FIO FUSION-IO, INC.
Common Stock
J - Other -1.000.000 17.538.379 -5,39
2012-02-27 2012-02-23 4 FIO FUSION-IO, INC.
Common Stock
J - Other 10.000 20.000 100,00
2012-02-27 2012-02-23 4 FIO FUSION-IO, INC.
Common Stock
J - Other -1.000.000 18.538.379 -5,12
2012-02-24 2012-02-23 4 INWK INNERWORKINGS INC
Common Stock
S - Sale -54.849 6.819.007 -0,80 11,75 -644.344 80.106.967
2012-02-24 2012-02-22 4 INWK INNERWORKINGS INC
Common Stock
S - Sale -253.211 6.873.856 -3,55 11,68 -2.957.808 80.294.887
2012-02-23 2012-02-21 4 FIO FUSION-IO, INC.
Common Stock
J - Other 10.000 10.000
2012-02-23 2012-02-21 4 FIO FUSION-IO, INC.
Common Stock
J - Other -1.000.000 19.538.379 -4,87
2012-02-14 2012-02-10 4 FIO FUSION-IO, INC.
Common Stock
J - Other 244 979 33,20
2012-02-14 2012-02-10 4 FIO FUSION-IO, INC.
Common Stock
J - Other -10.000 0 -100,00
2012-02-14 2012-02-10 4 FIO FUSION-IO, INC.
Common Stock
J - Other 10.000 10.000
2012-02-14 2012-02-10 4 FIO FUSION-IO, INC.
Common Stock
J - Other -1.000.000 20.538.379 -4,64
2012-02-09 2012-02-07 4 FIO FUSION-IO, INC.
Common Stock
J - Other 244 735 49,69
2012-02-09 2012-02-07 4 FIO FUSION-IO, INC.
Common Stock
J - Other -10.000 0 -100,00
2012-02-09 2012-02-07 4 FIO FUSION-IO, INC.
Common Stock
J - Other 10.000 10.000
2012-02-09 2012-02-07 4 FIO FUSION-IO, INC.
Common Stock
J - Other -1.000.000 21.538.379 -4,44
2012-02-06 2012-02-06 4 FIO FUSION-IO, INC.
Common Stock
S - Sale -23.083 64.634 -26,32 23,05 -532.063 1.489.814
2012-02-06 2012-02-02 4 FIO FUSION-IO, INC.
Common Stock
J - Other 491 491
2012-02-06 2012-02-02 4 FIO FUSION-IO, INC.
Common Stock
J - Other -20.000 0 -100,00
2012-02-06 2012-02-02 4 FIO FUSION-IO, INC.
Common Stock
J - Other 10.000 20.000 100,00
2012-02-06 2012-02-02 4 FIO FUSION-IO, INC.
Common Stock
J - Other -1.000.000 22.538.379 -4,25
2004-04-19 3 JNPR JUNIPER NETWORKS INC
Common Stock
288.014
2004-04-19 3 JNPR JUNIPER NETWORKS INC
Common Stock
42.471
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)